5,6-二甲基-1H-吲哚 | 30877-30-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 5,6-二甲基-1H-吲哚
• 英文名称: 5,6-dimethyl-indole
• 英文别名: 5,6-dimethyl-1H-indole；5,6-dimethylindole；dimethylindole；5,6-Dimethyl-indol；2,3-Dimethyl-indol
• CAS: 30877-30-6
• 化学式: C₁₀H₁₁N
• mdl: MFCD11521319
• 分子量: 145.204
• InChiKey: VQSHETACGYAGAQ-UHFFFAOYSA-N

物化性质

• 熔点：
  154-155 °C
• 沸点：
  198 °C(Press: 8 Torr)
• 密度：
  1.080±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  15.8
• 氢给体数：
  1
• 氢受体数：
  0

安全信息

• 海关编码：
  2933990090
• 危险性防范说明：
  P305+P351+P338
• 危险性描述：
  H319

反应信息

• 作为反应物：
  描述：

  5,6-二甲基-1H-吲哚 在 sodium cyanoborohydride 、 溶剂黄146 作用下， 反应 2.0h， 以90%的产率得到5,6-dimethyl-2,3-dihydro-1H-indole
  参考文献：
  名称：

  Regioselective Glycosylation: Synthesis of α-Indoline Nucleosides

  摘要：

  Novel indoline ribonucleosides with the alpha-N-glycoside configuration are synthesized with very high regioselectivily in 90-96% yield, using TMS protected indolines and 2,3-O-(1-methylethylidene)-5-O-(triphenylmethyl)-alpha/beta-D-ribofuranose. The structures of these ribonucleosides were elucidated with X-ray crystallography as well as 2D (NOESY COSY and HMQC) NMR spectroscopy.

  DOI：

  10.1081/ncn-200067398
• 作为产物：
  描述：

  N-(2,4,5-三甲基苯基)甲酰胺 在 potassium tert-butylate 作用下， 生成 5,6-二甲基-1H-吲哚
  参考文献：
  名称：

  Marion; Oldfield, Canadian Journal of Research, Section B: Chemical Sciences, 1947, vol. 25, p. 1,12

  摘要：

  DOI：

文献信息

• [EN] 5-SULFAMOYL-2-HYDROXYBENZAMIDE DERIVATIVES<br/>[FR] DÉRIVÉS DE 5-SULFAMOYL-2-HYDROXYBENZAMIDE
  申请人：GLAXOSMITHKLINE IP DEV LTD

  公开号：WO2017153952A1

  公开（公告）日：2017-09-14

  The invention is directed to substituted salicylamide derivatives. Specifically, the invention is directed to compounds according to Formula (I): wherein R, R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof. The compounds of the invention are inhibitors of CD73 and can be useful in the treatment of cancer, pre-cancerous syndromes and diseases associated with CD73 inhibition, such as AIDS, the treatment of HIV, autoimmune diseases, infections, atherosclerosis, and ischemia–reperfusion injury. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting CD73 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

  本发明涉及取代水杨酰胺衍生物。具体而言，本发明涉及根据公式(I)的化合物：其中R、R1和R2如本文所述，或其药用可接受的盐。本发明的化合物是CD73的抑制剂，可用于治疗癌症、前癌症综合症以及与CD73抑制相关的疾病，例如艾滋病、治疗HIV、自身免疫疾病、感染、动脉粥样硬化和缺血再灌注损伤。因此，本发明进一步涉及包含本发明化合物的药物组合物。本发明还进一步涉及使用本发明化合物或包含本发明化合物的药物组合物来抑制CD73活性和治疗与之相关的疾病的方法。
• [EN] MACROCYCLIC SPIROCARBAMATE DERIVATIVES AS FACTOR XIA INHIBITORS, PHARMACEUTICALLY ACCEPTABLE COMPOSITIONS AND THEIR USE<br/>[FR] DÉRIVÉ SPIROCARBAMATE MACROCYCLIQUE COMME INHIBITEURS DU FACTEUR XIA, COMPOSITIONS PHARMACEUTIQUEMENT ACCEPTABLES ET LEUR UTILISATION
  申请人：MERCK SHARP & DOHME

  公开号：WO2017074833A1

  公开（公告）日：2017-05-04

  The present invention provides a compound of Formula (I) and stereoisomers thereof, and pharmaceutically acceptable salts of said compounds and said stereoisomers, and pharmaceutical compositions thereof, and methods for using said compounds and compositions for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma kallikrein.

  本发明提供了一种式(I)的化合物及其立体异构体，以及所述化合物和所述立体异构体的药学上可接受的盐，以及其药物组合物，以及使用所述化合物和组合物用于治疗或预防血栓、栓塞、高凝血性或纤维变化的方法。这些化合物是选择性因子XIa抑制剂或因子XIa和血浆激肽原的双重抑制剂。
• Synthesis of 3-acylindoles via decarboxylative cross-coupling reaction of free (NH) indoles with α-oxocarboxylic acids
  作者：Li-Jun Gu、Ji-Yan Liu、Li-Zhu Zhang、Yong Xiong、Rui Wang

  DOI：10.1016/j.cclet.2013.10.004

  日期：2014.1

  Abstract A convenient and general method for acylation of free (N H) indoles via palladium-catalyzed decarboxylative cross-coupling reaction was developed. This process provided a useful method for the preparation of diverse 3-acylindoles in high yields utilizing a reaction with readily accessible reactants under mild conditions.

  摘要提出了一种方便，通用的钯催化脱羧交叉偶联反应对游离（NH）吲哚进行酰化的方法。该方法提供了在温和条件下利用与易于获得的反应物的反应以高收率制备各种3-酰基吲哚的有用方法。
• Intermediates for indoles
  申请人：Hoffmann-La Roche Inc.

  公开号：US03976639A1

  公开（公告）日：1976-08-24

  Ortho-nitrotoluenes are condensed with formamide acetals to yield the corresponding otho-nitro-.beta.-aminestyrenes which undergo cyclization upon reduction to yield indoles.

  邻硝基甲苯与甲酰胺缩醛反应，生成相应的邻硝基-β-氨基苯乙烯，经还原后发生环化反应生成吲哚。
• QUINUCLIDINES FOR MODULATING ALPHA 7 ACTIVITY
  申请人：CoMentis, Inc.

  公开号：US20160009706A1

  公开（公告）日：2016-01-14

  Provided are substituted quinuclidine compounds, pharmaceutical compositions comprising such compounds, and methods of modulating α7 nicotinic acetylcholine receptors and treating neurological disorders using such compounds.

  提供了替代性的喹诺啡啶化合物，包括这些化合物的药物组合物，以及使用这些化合物调节α7烟碱乙酰胆碱受体和治疗神经系统疾病的方法。